Jonathan Kerr

Source: Invest in ME

Jonathan Ricardo Kerr, BSc, MBBCh, MD, PhD, FRCPath, is a British researcher who became interested in ME/CFS after studying the consequences of Parvovirus B19 infection and finding that some of those infected went on to develop CFS. Formerly of St. George’s University of London, he is presently working as an Associate professor in the School of Medicine and Health Sciences at Universidad del Rosario, Bogotá, Colombia.

Notable studies

• 2016, Prevalencia de síntomas de fatiga crónica / encefalomielitis miálgica (SFC/EM) y su relación con factores ocupacionales en trabajadores en una empresa de vigilancia en Bogotá, Colombia (Jonathan Kerr) Note: This study did not use PEM as a inclusionary symptom nor did it use any Definitions of ME and CFS including the most symptom liberal of valid definitions, SEID. The only entry criteria noted were fatigue and muscle pain which seem to be the broadest and loose of symptom definitions Reeves criteria and Oxford criteria.
• 2016, MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in [[Natural killer cell|Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME) (Full Text)
• 2014, Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) (Abstract)
• 2010, Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis (Full Text)
• 2009, Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (Full Text)
• 2007, Review - Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: disease mechanisms, a diagnostic test and specific treatments (Full Text)
• 2005, Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome (Full Text)
• 2005, Association of chronic fatigue syndrome with human leucocyte antigen class II alleles (Full Text)
• 1997, Parvovirus B19 and Chronic Fatigue Syndrome (Abstract)

Talks & interviews

• 2015, Spoonie Radio episode 14 - Jonathan Kerr
• 2014, Dr. Kerr, I presume?

Invest in ME International ME Conference

• 2010, Speaker at the 5th Invest in ME International ME Conference on Study of SNPs to determine subtype status in CFS patients DVD available
• 2009, Speaker at the 4th Invest in ME International ME Conference on Severely-affected Sub Groups of ME/CFS DVD available
• 2008, Speaker at the 3rd Invest in ME International ME Conference on Gene Expression in ME/CFS: a means of Subtyping DVD available
• 2007, at the 2nd Invest in ME International ME Conference on Case Study - Biomedical research (A view of a biomedical research team, how it is funded, what it needs, how it could be improved, what the future research would look like) DVD available
• 2006, Speaker at the 1st Invest in ME International ME Conference on Viral and Human Gene Expression, development of diagnostic test, news of clinical trials DVD available

Online presence

• Invest in ME - Jonathan Kerr
• PubMed - Jonathan Kerr

Learn more

• Jonathan Kerr

antibodies Antibody/immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

biomedical research basic medical research on organisms, such as humans or other living things, that helps increase medical knowledge. (Learn more: me-pedia.org)

biomedical research basic medical research on organisms, such as humans or other living things, that helps increase medical knowledge. (Learn more: me-pedia.org)

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.